GlobeNewswire by notified

BBS-Bioactive Bone Substitutes: 69% of the warrants 1-2022 (WA1) used for the subscription of shares, company raises EUR 213 000 in gross proceeds

Share

BBS-Bioactive Bone Substitutes Oyj, Company Announcement, 9 December 2022 at 2.15 p.m. EET

BBS-Bioactive Bone Substitutes: 69% of the warrants 1-2022 (WA1) used for the subscription of shares, company raises EUR 213 000 in gross proceeds

The subscription period for BBS-Bioactive Bone Substitutes Oyj's first series of warrants 1-2022 (WA1) ended on 2 December 2022. In total, 231,415 warrants 1-2022 (WA1) were used, corresponding to approximately 69.0 percent of the total number of warrants. BBS-Bioactive Bone Substitutes Oyj received approximately EUR 213 000 in gross proceeds before expenses. The company's Board of Directors has today approved the share subscriptions.

The subscription price was EUR 0.92 and SEK 10.10 per share. The subscription period for the shares was 21 November – 2 December 2022.

The shares are expected to be registered in the trade register on 16 December 2022 and trading is estimated to begin on 19 December 2022. The warrants which were not used to subscribe to the shares will be removed from the book-entry accounts of shareholders.

Following the registration of the new shares, the total number of shares in BBS-Bioactive Bone Substitutes Oyj will be 10,177,874 of which 509,523 are treasury shares held by the company.

For more information:

Ilkka Kangasniemi, CEO,
tel. +358 40 708 0307, e-mail: ilkka.kangasniemi@bbs-artebone.fi

Certified Advisor:
Nordic Certified Adviser AB, tel. +46 70 551 67 29, info@certifiedadviser.se

BBS in brief

BBS-Bioactive Bone Substitutes is a health technology company that started operations in 2003. We have developed a new product for the treatment of severe bone fractures and lumber problems. Our goal is to provide a new generation of medical products for the treatment of bone damage in orthopaedic surgery. In the pharmaceutical sector, development and research requires perseverance and courage to develop new things. We have evidence of this for over 20 years. Our activities are characterised by top expertise, innovation and employees who are enthusiastic and committed to their work. The ARTEBONE ® in the final stages of product development, and we are looking for a CE marking that enables commercialisation in the EU. We are a company in Oulu with a pharmaceutical factory permit in Reisjärvi.

BBS-Bioactive Bone Substitutes Oyj:n shares are listed in Nasdaq First North Growth Market Finland and Nasdaq First North Growth Market Sweden.

More information: www.bbs-artebone.fi

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

Nokia Corporation: Repurchase of own shares on 06.02.20236.2.2023 20:00:00 CET | Press release

Nokia Corporation Stock Exchange Release 6 February 2023 at 21:00 EET Nokia Corporation: Repurchase of own shares on 06.02.2023 Espoo, Finland – On 6 February 2023 Nokia Corporation (LEI: 549300A0JPRWG1KI7U06) has acquired its own shares (ISIN FI0009000681) as follows: Trading venue (MIC Code)Number of sharesWeighted average price / share, EUR*XHEL272,4334.39CEUX26,2024.39AQEU5,1794.39TQEX10,1864.38Total314,0004.39 * Rounded to two decimals On 3 February 2022, Nokia announced that its Board of Directors is initiating a share buyback program under the authorization granted by Nokia’s Annual General Meeting on 8 April 2021 to return up to EUR 600 million of cash to shareholders in tranches over a period of two years. The second phase of the share buyback program in compliance with the Market Abuse Regulation (EU) 596/2014 (MAR), the Commission Delegated Regulation (EU) 2016/1052 and under the authorization granted by Nokia’s Annual General Meeting on 5 April 2022 started on 2 January 202

EMGS reports fourth quarter 2022 results6.2.2023 20:00:00 CET | Press release

Electromagnetic Geoservices ASA’s (“EMGS” or the “Company”) financial report and market presentation for the fourth quarter of 2022 are attached. Highlights: * The Company recorded revenues of USD 15.2 million, up from USD 5.1 million in the fourth quarter of 2021 and up from USD 6.6 million in the third quarter of 2022. * Adjusted EBITDA (including capitalised multi-client expenses and vessel and office lease expenses) of USD 8.2 million, up from USD 0.4 million in the fourth quarter of 2021. * Free cash increased with USD 56 thousand during the quarter, to USD 11.4 million. * Trade receivables at the end of the quarter were USD 7.9 million. * The Atlantic Guardian is currently in warm-stack in Norway. A pre-recorded presentation will be available over the internet from 20:00 (local time Norway) today. To access the presentation, please go to the Company’s homepage (www.emgs.com) and follow the link. Contact Anders Eimstad, Chief Financial Officer, +47 94 82 58 36 About EMGS EMGS, the

ETC’s Aircrew Training Systems Unit Awarded $85 Million Contract6.2.2023 19:48:27 CET | Press release

SOUTHAMPTON, Pa., Feb. 06, 2023 (GLOBE NEWSWIRE) -- Environmental Tectonics Corporation (OTC Pink: ETCC) (“ETC” or the “Company”) announced that its Aircrew Training Systems business unit (“ATS”) was awarded an $85 million contract for the delivery of an Aeromedical Center including the building and all related facilities, in addition to the following products: Authentic tactical flight simulator (“ATFS-400 25”),GL – 1500 spatial disorientation trainer,Altitude chamber (12 person),Portable hyperbaric chamber,Ejection seat simulator,Night vision/night vision goggle training system, andA water survival system. The services portion of this contract provides integrated logistics services, pilot physiology and personnel training services through ETC’s NASTAR Center and facility support services. “This contract represents another significant milestone for ETC. We are pleased to have been chosen to supply our ATS customer with an Aeromedical Center with products and services designed to aid t

Hexagon Purus ASA: Update to financial calendar 2023 and Q4 2022 trading update6.2.2023 19:48:00 CET | Press release

(Oslo, 6 February 2023) Reference is made to the stock exchange announcement issued on 6 February 2023 at 19:44 CET. The Board of Directors of Hexagon Purus ASA has today decided to move the reporting date for the Company’s Q4 2022 and 2022 Annual reports to 25 April 2023. Consequently, the annual general meeting is moved to 25 May 2023. This change is made to facilitate the preparations required for a potential transfer of the Company’s shares to the main list of the Oslo Stock Exchange. A final decision by the Board of Directors to apply for a transfer to the main list of the Oslo Stock Exchange will be subject to prevailing market conditions at that time. In the absence of Q4 2022 reporting in the near term, Hexagon Purus has decided to provide the following preliminary estimates and unaudited figures for Q4 and full year 2022: Q4 2022 revenue of approximately NOK 370 million and full year 2022 revenue of approximately NOK 960 millionQ4 2022 EBITDA of approximately NOK -110 million